|
Volumn 46, Issue 5, 2014, Pages 418-419
|
MDA5 and autoimmune disease
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CELL DNA;
COMPLEMENT COMPONENT C1Q;
COMPLEMENT COMPONENT C2;
COMPLEMENT COMPONENT C4;
DOUBLE STRANDED RNA;
PATTERN RECOGNITION RECEPTOR;
VIRUS DNA;
VIRUS RNA;
DOUBLE STRANDED RNA MDA5;
INTERFERON;
RNA HELICASE;
UNCLASSIFIED DRUG;
AICARDI GOUTIERES SYNDROME;
ALLELE;
AUTOIMMUNE DISEASE;
DISABILITY;
DYSTONIA;
ENVIRONMENTAL FACTOR;
GAIN OF FUNCTION MUTATION;
GENE SEQUENCE;
HUMAN;
MYELINATED NERVE;
NERVE FIBER;
NONHUMAN;
NUCLEIC ACID METABOLISM;
PHENOTYPE;
PRIORITY JOURNAL;
REVIEW;
SPASTICITY;
SYSTEMIC LUPUS ERYTHEMATOSUS;
TRANSCRIPTION INITIATION;
VIRUS INFECTION;
VIRUS PATHOGENESIS;
VIRUS REPLICATION;
AUTOIMMUNITY;
DISEASE PREDISPOSITION;
GENE MUTATION;
GENETIC ASSOCIATION;
GENETIC PREDISPOSITION;
GENETIC VARIABILITY;
IMMUNE RESPONSE;
IMMUNOPATHOGENESIS;
PROTEIN PROTEIN INTERACTION;
SHORT SURVEY;
UPREGULATION;
VIRUS MUTATION;
AUTOIMMUNE DISEASES OF THE NERVOUS SYSTEM;
DEAD-BOX RNA HELICASES;
HUMANS;
INTERFERON TYPE I;
MODELS, MOLECULAR;
MUTATION;
NERVOUS SYSTEM MALFORMATIONS;
PHENOTYPE;
SIGNAL TRANSDUCTION;
|
EID: 84899534322
PISSN: 10614036
EISSN: 15461718
Source Type: Journal
DOI: 10.1038/ng.2959 Document Type: Review |
Times cited : (21)
|
References (14)
|